Found: 203
Select item for more details and to access through your institution.
Correction to: Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
- Published in:
- 2022
- Publication type:
- Correction Notice
Reductions in Antibiotic Prescribing in Australia During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: National Prescribing Data.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
"Never Once Have I Ever Been Bored"—Exciting Times Ahead for Clinical Infectious Diseases.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 1, doi. 10.1093/cid/ciac286
- By:
- Publication type:
- Article
Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e536, doi. 10.1093/cid/ciac279
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e361, doi. 10.1093/cid/ciac275
- By:
- Publication type:
- Article
Nasty Human Immunodeficiency Virus Type 1 (HIV-1) Variant.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. i, doi. 10.1093/cid/ciac365
- Publication type:
- Article
Correction to: Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2–Related Illness in Children: Hospital Experience in Cape Town, South Africa.
- Published in:
- 2022
- Publication type:
- Correction Notice
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e1, doi. 10.1093/cid/ciac278
- By:
- Publication type:
- Article
Correction to: Multisystem Inflammatory Syndrome in Children—United States, February 2020–July 2021.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e545, doi. 10.1093/cid/ciac262
- By:
- Publication type:
- Article
High Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission Rates Detected by Dense Saliva Sampling.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e10, doi. 10.1093/cid/ciac261
- By:
- Publication type:
- Article
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June–July 2021.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e20, doi. 10.1093/cid/ciac240
- By:
- Publication type:
- Article
Correction to: A Rare Mutation in SPLUNC1 Affects Bacterial Adherence and Invasion in Meningococcal Disease.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 184, doi. 10.1093/cid/ciac263
- Publication type:
- Article
Clinical and Virological Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta) Variant: A Prospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e27, doi. 10.1093/cid/ciac239
- By:
- Publication type:
- Article
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e552, doi. 10.1093/cid/ciac238
- By:
- Publication type:
- Article
High Asymptomatic Carriage With the Omicron Variant in South Africa.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e289, doi. 10.1093/cid/ciac237
- By:
- Publication type:
- Article
Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e347, doi. 10.1093/cid/ciac235
- By:
- Publication type:
- Article
Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e564, doi. 10.1093/cid/ciac234
- By:
- Publication type:
- Article
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e368, doi. 10.1093/cid/ciac224
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e865, doi. 10.1093/cid/ciac223
- By:
- Publication type:
- Article
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Pediatric Age on Delta Variant Household Transmission.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e35, doi. 10.1093/cid/ciac219
- By:
- Publication type:
- Article
Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020–October 2021
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e572, doi. 10.1093/cid/ciac212
- By:
- Publication type:
- Article
Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e44, doi. 10.1093/cid/ciac203
- By:
- Publication type:
- Article
Coronavirus Disease 2019's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e102, doi. 10.1093/cid/ciac204
- By:
- Publication type:
- Article
SARS-CoV-2 in Exhaled Aerosol Particles from COVID-19 Cases and Its Association to Household Transmission.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e50, doi. 10.1093/cid/ciac202
- By:
- Publication type:
- Article
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273– and BNT162b2-Vaccinated Individuals.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e869, doi. 10.1093/cid/ciac201
- By:
- Publication type:
- Article
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e525, doi. 10.1093/cid/ciac199
- By:
- Publication type:
- Article
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 After the Second Wave in South Africa in Human Immunodeficiency Virus–Infected and Uninfected Persons: A Cross-Sectional Household Survey.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e57, doi. 10.1093/cid/ciac198
- By:
- Publication type:
- Article
Reply to Klein and Harris.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e312, doi. 10.1093/cid/ciac190
- By:
- Publication type:
- Article
Reply to Izurieta et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e69, doi. 10.1093/cid/ciac174
- By:
- Publication type:
- Article
Recommendation to Take a Holistic View of the Dynamic Pathogenic Pneumococcal Environment.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e579, doi. 10.1093/cid/ciac178
- By:
- Publication type:
- Article
Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e938, doi. 10.1093/cid/ciac182
- By:
- Publication type:
- Article
Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e928, doi. 10.1093/cid/ciac184
- By:
- Publication type:
- Article
Examining the Robustness of 3 Versus 6 Feet of Physical Distancing in Schools: A Reanalysis of van den Berg et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e955, doi. 10.1093/cid/ciac175
- By:
- Publication type:
- Article
Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e947, doi. 10.1093/cid/ciac179
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placental Infection Is Associated With Massive Perivillous Fibrin Deposition at the Maternal-Fetal Interface: A Preliminary Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e1176, doi. 10.1093/cid/ciac173
- By:
- Publication type:
- Article
Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitals: Effects of Aerosol-Generating Procedures, HEPA-Filtration Units, Patient Viral Load, and Physical Distance.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e89, doi. 10.1093/cid/ciac161
- By:
- Publication type:
- Article
Probable Animal-to-Human Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant AY.127 Causing a Pet Shop-Related Coronavirus Disease 2019 (COVID-19) Outbreak in Hong Kong.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e76, doi. 10.1093/cid/ciac171
- By:
- Publication type:
- Article
Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory Tract.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e82, doi. 10.1093/cid/ciac170
- By:
- Publication type:
- Article
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e585, doi. 10.1093/cid/ciac169
- By:
- Publication type:
- Article
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e594, doi. 10.1093/cid/ciac167
- By:
- Publication type:
- Article
Immunity Against the Omicron Variant From Vaccination, Recovery, or Both.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e672, doi. 10.1093/cid/ciac172
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Intranasal or Intratesticular Route Induces Testicular Damage.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e974, doi. 10.1093/cid/ciac142
- By:
- Publication type:
- Article
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e380, doi. 10.1093/cid/ciac153
- By:
- Publication type:
- Article
Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e962, doi. 10.1093/cid/ciac151
- By:
- Publication type:
- Article
Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC).
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor